- Home
- TLSA vs SOPH Comparison
TLSA vs SOPH Comparison
Compare TLSA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- SOPH
- Stock Information
- Founded
- TLSA 2013
- SOPH 2011
- Country
- TLSA United Kingdom
- SOPH Switzerland
- Employees
- TLSA 9
- SOPH N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLSA Health Care
- SOPH Health Care
- Exchange
- TLSA Nasdaq
- SOPH Nasdaq
- Market Cap
- TLSA 196.1M
- SOPH 231.8M
- IPO Year
- TLSA 2000
- SOPH 2021
- Fundamental
- Price
- TLSA $1.70
- SOPH $4.30
- Analyst Decision
- TLSA
- SOPH Strong Buy
- Analyst Count
- TLSA 0
- SOPH 1
- Target Price
- TLSA N/A
- SOPH $7.00
- AVG Volume (30 Days)
- TLSA 226.1K
- SOPH 121.2K
- Earning Date
- TLSA 01-01-0001
- SOPH 11-04-2025
- Dividend Yield
- TLSA N/A
- SOPH N/A
- EPS Growth
- TLSA N/A
- SOPH N/A
- EPS
- TLSA N/A
- SOPH N/A
- Revenue
- TLSA N/A
- SOPH $73,297,000.00
- Revenue This Year
- TLSA N/A
- SOPH $16.60
- Revenue Next Year
- TLSA N/A
- SOPH $19.09
- P/E Ratio
- TLSA N/A
- SOPH N/A
- Revenue Growth
- TLSA N/A
- SOPH 13.66
- 52 Week Low
- TLSA $0.63
- SOPH $2.58
- 52 Week High
- TLSA $2.60
- SOPH $5.30
- Technical
- Relative Strength Index (RSI)
- TLSA 40.73
- SOPH 49.45
- Support Level
- TLSA $1.60
- SOPH $4.21
- Resistance Level
- TLSA $1.81
- SOPH $4.70
- Average True Range (ATR)
- TLSA 0.13
- SOPH 0.38
- MACD
- TLSA -0.02
- SOPH -0.05
- Stochastic Oscillator
- TLSA 23.40
- SOPH 27.13
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.